Cytdyn napkin needs: Natera Vs Pharma I blabbled

New Post Public Reply Private Reply Replies (0) Message Board
My69z
173
Cytdyn napkin needs:
Natera Vs Pharma

I blabbled many oh of times that we do not "need" "big" pharma. Have nothing to offer us --- Mgt, doctors or drugs & Dr. J will let THEM, know when & how, they can enter, because we can hire 3rd-parties if/as needed. With it's possible another company or a consortium, wants into pharma & no better timing than through Leronlimab.

*Natera:
50% of US oncologist use Signatera. FDA approved for breast, other cancers & ICI combo approved

*Reny Aniline reports to John Fesko:
Joining Natera in 2014, Fesko has overseen the company's business development, pharmaceutical services, and market access, making him a central figure in orchestrating large-scale pharmaceutical collaborations.(Natera)

Remember months back Dr. J said he dose not imagine Cytodyn marketing Leronlimab, ourselves. Mr. Fesko surely has a few ideas. Validating Dr. J's coy response. : )

*Pharma: Nothing that Cytodyn can not create if chooses

We now clearly know Cytodn does not depend on their toxic drugs, for LL success

Looking like Natera is & will be why, pharma has been regulated to waiting outside the Cytodyn conference room
...

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

NVIDIA Launches Quantum Research Center to Transform Computing

Updated Category News Views 205

NVIDIA Establishes a Quantum Research Center for Innovation NVIDIA has taken a significant step towards the future of technology by announcing the development of a cutting-edge research center focused on quantum computing. Introducing the NVIDIA Accelerated Quantum Research Center The newly formed NVIDIA Accelerated Quantum Research Center, or NVAQC, is strategically...

Continue Reading
Discover the New GloFish® Electric Green® Angelfish Today!

Updated Category News Views 459

Introducing the GloFish® Electric Green® Angelfish Spectrum Brands, Inc. has exciting news for aquarium enthusiasts! They have unveiled the latest addition to their vibrant family of GloFish® fluorescent fish: the GloFish® Electric Green® Angelfish. This beautiful new color adds to the popularity of the GloFish® collection, following the successful release of the...

Continue Reading
Affimed's CEO to Feature at Upcoming Healthcare Conference

Updated Category News Views 127

Affimed CEO to Participate in Global Healthcare Conference Affimed N.V. (NASDAQ: AFMD), a clinical-stage immuno-oncology company, is excited to announce that its Chief Executive Officer, Dr. Shawn Leland, will be engaging in a fireside chat at a noteworthy healthcare conference. This event, which promises to highlight advancements in the healthcare sector, is set for a...

Continue Reading
Masimo Reveals Preliminary 2024 Financial Results and Plans

Updated Category News Views 282

Masimo Corporation's Preliminary Financial Results for 2024 Masimo Corporation (NASDAQ: MASI) has recently unveiled its select preliminary financial results for the fourth quarter and full-year ending December 28, 2024, along with its initial guidance for the fiscal year 2025. The company’s commitment to enhancing patient outcomes and the cost of care continues to...

Continue Reading
Tile Shop Prepares for Upcoming Earnings Call in November

Updated Category News Views 75

Tile Shop Earnings Call Scheduled for November Tile Shop Holdings, Inc. (TTSH), a leading specialty retailer in the tile industry, has announced its plans to release its financial results for the third quarter in early November. The announcement marks an essential update for investors and stakeholders who are keen on the company’s financial performance. Details of the...

Continue Reading